Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
KMDA
Kamada Ltd. KMDA
$7.45
โ–ฒ +0.00% 24H
3.196.7310.2713.8017.342013-052016-082019-122023-032026-06

About

Kamada Ltd. is a biopharmaceutical company specializing in the development, production, and marketing of specialty plasma-derived protein therapeutics. Its primary purpose is to provide innovative medical solutions for unmet clinical needs, particularly in the fields of immunology, respiratory diseases, and critical caโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryIsrael
Employees462
TickerKMDA

Statistics

Market Cap$429.8M
Revenue (TTM)$180.5M
Net Income$20.2M
Net Margin11.2%
EPS$0.35
P/E21.26
P/S2.37
P/B1.65
EV/EBITDA9.11
ROE8.0%
Dividend Yield13.44%
Price$7.45

Data: Twelve Data ยท Revenue = mcap / P/S

Kamada Ltd. (KMDA) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap